EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · IEX Real-Time Price · USD
7.28
-0.12 (-1.62%)
Apr 26, 2024, 4:30 PM EDT - Market closed

EDAP TMS Revenue

In the year 2023, EDAP TMS had annual revenue of $67.14M with 14.52% growth. Revenue in the quarter ending December 31, 2023 was $21.79M with 30.34% year-over-year growth.

Revenue (ttm)
$67.14M
Revenue Growth
+14.52%
P/S Ratio
4.02
Revenue / Employee
$218,686
Employees
307
Market Cap
270.12M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202367.14M8.51M14.52%
Dec 31, 202258.63M8.55M17.08%
Dec 31, 202150.07M-733.45K-1.44%
Dec 31, 202050.81M344.40K0.68%
Dec 31, 201950.46M5.42M12.05%
Dec 31, 201845.04M2.14M4.99%
Dec 31, 201742.90M5.42M14.46%
Dec 31, 201637.48M2.45M6.98%
Dec 31, 201535.03M2.62M8.09%
Dec 31, 201432.41M-705.63K-2.13%
Dec 31, 201333.11M-1.27M-3.69%
Dec 31, 201234.38M5.52M19.14%
Dec 31, 201128.86M-2.84M-8.96%
Dec 31, 201031.70M-3.98M-11.17%
Dec 31, 200935.68M3.55M11.06%
Dec 31, 200832.13M-508.42K-1.56%
Dec 31, 200732.64M5.97M22.39%
Dec 31, 200626.66M2.08M8.44%
Dec 31, 200524.59M-5.46M-18.18%
Dec 31, 200430.05M6.79M29.19%
Dec 31, 200323.26M2.32M11.06%
Dec 31, 200220.95M-356.44K-1.67%
Dec 31, 200121.30M-4.21M-16.50%
Dec 31, 200025.51M5.04M24.64%
Dec 31, 199920.47M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vanda Pharmaceuticals 192.64M
Sutro Biopharma 153.73M
Nanobiotix 40.23M
Inovio Pharmaceuticals 832.01K
Opthea 385.28K
Revenue Rankings